National Health Investors, Inc. (NYSE:NHI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Thursday. The brokerage presently has a $89.00 price objective on the real estate investment trust’s stock. Zacks Investment Research‘s price target would suggest a potential upside of 15.86% from the stock’s previous close.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

Several other equities research analysts also recently weighed in on NHI. ValuEngine downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. Stifel Nicolaus lifted their price target on shares of National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Wednesday, June 21st. Mizuho reaffirmed a “neutral” rating on shares of National Health Investors in a research note on Wednesday, June 28th. BidaskClub raised shares of National Health Investors from a “hold” rating to a “buy” rating in a research note on Thursday, June 29th. Finally, KeyCorp reaffirmed a “hold” rating on shares of National Health Investors in a research note on Sunday, September 17th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $80.50.

Shares of National Health Investors (NYSE:NHI) traded down 2.80% during trading on Thursday, hitting $76.82. 432,867 shares of the stock traded hands. National Health Investors has a 1-year low of $66.31 and a 1-year high of $81.29. The firm has a market capitalization of $3.15 billion, a price-to-earnings ratio of 19.73 and a beta of 0.56. The firm has a 50-day moving average of $78.73 and a 200-day moving average of $76.04.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing the consensus estimate of $1.29 by ($0.36). National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The company had revenue of $69.84 million during the quarter, compared to the consensus estimate of $67.68 million. During the same period last year, the firm posted $1.22 earnings per share. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. On average, equities analysts forecast that National Health Investors will post $3.85 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “National Health Investors, Inc. (NHI) Stock Rating Upgraded by Zacks Investment Research” was originally reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/09/23/national-health-investors-inc-nhi-stock-rating-upgraded-by-zacks-investment-research-2.html.

In other news, insider Kevin Carlton Pascoe sold 2,000 shares of National Health Investors stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $79.80, for a total transaction of $159,600.00. Following the completion of the transaction, the insider now directly owns 21,228 shares in the company, valued at $1,693,994.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 5.19% of the stock is owned by company insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the company. US Bancorp DE grew its holdings in shares of National Health Investors by 0.5% during the second quarter. US Bancorp DE now owns 8,836 shares of the real estate investment trust’s stock valued at $700,000 after buying an additional 44 shares during the last quarter. Woodmont Investment Counsel LLC grew its holdings in shares of National Health Investors by 1.3% during the second quarter. Woodmont Investment Counsel LLC now owns 3,414 shares of the real estate investment trust’s stock valued at $270,000 after buying an additional 45 shares during the last quarter. Teacher Retirement System of Texas grew its holdings in shares of National Health Investors by 2.0% during the second quarter. Teacher Retirement System of Texas now owns 3,192 shares of the real estate investment trust’s stock valued at $253,000 after buying an additional 62 shares during the last quarter. QS Investors LLC grew its holdings in shares of National Health Investors by 0.8% during the second quarter. QS Investors LLC now owns 7,934 shares of the real estate investment trust’s stock valued at $628,000 after buying an additional 62 shares during the last quarter. Finally, Family Legacy Inc. grew its holdings in shares of National Health Investors by 0.4% during the second quarter. Family Legacy Inc. now owns 17,115 shares of the real estate investment trust’s stock valued at $1,355,000 after buying an additional 65 shares during the last quarter. Hedge funds and other institutional investors own 70.67% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.